We next applied our developed ddPCR assay protocol to assess breakpoints specific to the TERT-rearranged high-risk neuroblastoma diagnosed in patient P1 by TERT break-apart FISH (Supplementary Fig. S2A) and hybrid capture–based panel sequencing (Supplementary Tables S1 and S4). The gene discussed is TERT; the disease is neuroblastoma.